Southampton Healthcare, Inc.
Quick facts
Marketed products
- Biktarvy Tab · Infectious Disease / Virology
Biktarvy is a fixed-dose combination antiretroviral that inhibits HIV reverse transcriptase and integrase while blocking the CCR5 co-receptor to prevent viral replication and CD4+ T-cell infection.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Southampton Healthcare, Inc.
What are Southampton Healthcare, Inc.'s marketed drugs?
Top marketed products include Biktarvy Tab.
Related
- Biktarvy Tab · Infectious Disease / Virology
- Sector hub: All tracked pharma companies